These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 26113682

  • 1. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania.
    Kroidl I, Clowes P, Reither K, Mtafya B, Rojas-Ponce G, Ntinginya EN, Kalomo M, Minja LT, Kowuor D, Saathoff E, Kroidl A, Heinrich N, Maboko L, Bates M, O'Grady J, Zumla A, Hoelscher M, Rachow A.
    Eur Respir J; 2015 Sep; 46(3):761-70. PubMed ID: 26113682
    [Abstract] [Full Text] [Related]

  • 2. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
    Gina P, Randall PJ, Muchinga TE, Pooran A, Meldau R, Peter JG, Dheda K.
    BMC Infect Dis; 2017 May 12; 17(1):339. PubMed ID: 28499418
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J, Theron G, Chanda D, Clowes P, Rachow A, Lesosky M, Hoelscher M, Mwaba P, Pym A, Dheda K, TB-NEAT team.
    BMC Infect Dis; 2015 Jul 09; 15():262. PubMed ID: 26156025
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD, Kerkhoff AD, Vogt M, Wood R.
    AIDS; 2012 Aug 24; 26(13):1635-43. PubMed ID: 22555166
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.
    Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A.
    PLoS One; 2010 Mar 24; 5(3):e9848. PubMed ID: 20352098
    [Abstract] [Full Text] [Related]

  • 11. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children.
    LaCourse SM, Pavlinac PB, Cranmer LM, Njuguna IN, Mugo C, Gatimu J, Stern J, Walson JL, Maleche-Obimbo E, Oyugi J, Wamalwa D, John-Stewart G.
    AIDS; 2018 Jan 02; 32(1):69-78. PubMed ID: 29028662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A, Corbett EL, Wilson D, van Oosterhout JJ, Dheda K, Huerga H, Peter J, Bonnet M, Alufandika-Moyo M, Grint D, Lawn SD, Fielding K.
    PLoS Med; 2019 Apr 02; 16(4):e1002776. PubMed ID: 30951533
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry.
    Amin AG, De P, Spencer JS, Brennan PJ, Daum J, Andre BG, Joe M, Bai Y, Laurentius L, Porter MD, Honnen WJ, Choudhary A, Lowary TL, Pinter A, Chatterjee D.
    Tuberculosis (Edinb); 2018 Jul 02; 111():178-187. PubMed ID: 30029905
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H, Mathabire Rucker SC, Cossa L, Bastard M, Amoros I, Manhiça I, Mbendera K, Telnov A, Szumilin E, Sanchez-Padilla E, Molfino L.
    PLoS Med; 2019 Apr 02; 16(4):e1002792. PubMed ID: 31039161
    [Abstract] [Full Text] [Related]

  • 18. Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia.
    Sahle SN, Asress DT, Tullu KD, Weldemariam AG, Tola HH, Awas YA, Hagos GG, Worku MG, Misgina DK.
    BMC Res Notes; 2017 Jan 31; 10(1):74. PubMed ID: 28137314
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients.
    Mutetwa R, Boehme C, Dimairo M, Bandason T, Munyati SS, Mangwanya D, Mungofa S, Butterworth AE, Mason PR, Corbett EL.
    Int J Tuberc Lung Dis; 2009 Oct 31; 13(10):1253-9. PubMed ID: 19793430
    [Abstract] [Full Text] [Related]

  • 20. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria.
    Wood R, Racow K, Bekker LG, Middelkoop K, Vogt M, Kreiswirth BN, Lawn SD.
    BMC Infect Dis; 2012 Feb 27; 12():47. PubMed ID: 22369353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.